A pioneer in Interventional Oncology, Dr. Jeff Geschwind developed breakthrough cancer therapies targeting tumor metabolism and founded a company to advance clinical trials for liver and pancreatic cancer. His leadership at Johns Hopkins, Yale, NAMSA, and USA Clinics Group has reshaped the future of oncologic innovation. https://www.slideshare.net/slideshow/dr-jeff-geschwind-a-leading-innovator-in-oncology-and-interventional-radiology-docx/276648186